Saturday, October 23, 2021
Coronavirus
Data Center
Economic Activity
Education
Financial Services
Food & Agriculture
Government
Health Services
Manufacturing
Nonprofit
Real Estate
Technology

TOPICS

Home Tags Amgen

Tag: Amgen

CLOSE EYE: From left, associate manufacturer Adeline Lamothe, manufacturing process technician contract worker Austin White and associate manufacturer David Folco check the single-use bioreactors, which are used to control the conditions for generating protein cells at Amgen Rhode Island in West Greenwich. / COURTESY AMGEN INC.

Team approach allows Amgen to complete new biomanufacturing plant in 2020

Health Services
PBN Manufacturing Awards 2021 Overall Excellence at an Enterprise Manufacturer: Amgen Rhode Island Amgen Inc. develops medications for oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and...
GOV. GINA M. RAIMONDO announced plans to allocate $45 million of COVID-19 relief funds to workforce development programs for those left jobless due to the pandemic. PBN FILE PHOTO/DAVE HANSEN

Raimondo announces $45M in workforce development for the unemployed

Coronavirus
PROVIDENCE – In an effort to break down traditional barriers to hiring, Gov. Gina M. Raimondo announced on Tuesday an investment of $45 million...
AMGEN said it is pulling the higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of the drug. The drug is manufactured n Rhode Island. / BLOOMBERG NEWS FILE PHOTO

Amgen pulls high-price version of Repatha in bid to raise sales

Health Services
NEW YORK – Amgen Inc. will pull its higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of...

Five Questions With: Carol Malysz

Health Services
In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and...

Amgen will buy Celgene drug in $13.4B antitrust sale

Health Services
BOSTON – Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to...
EARLY RESULTS FROM early results from an experimental therapy developed by Amgen showed promise in colon cancer. / BLOOMBERG FILE PHOTO

Amgen stock climbs on cancer drug promise

Technology
NEW YORK – Shares of Amgen Inc. rose as much as 2.3% in pre-market trading after early results from an experimental therapy showed promise...
PBN PHOTO/MIKE SKORSKI

JENNIFER LYTLE, 36

PBN Award Winners
40 Under Forty 2019 winner: JENNIFER LYTLE | 36 QUALITY ASSURANCE MANAGER, AMGEN RHODE ISLAND What is the best advice you have ever received? Success and failures...
BROADENED MISSION: Carol Malysz, executive director of Providence-based biotechnology trade association RI BIO, said the group has broadened its focus. Previously known as MedMates, this year the company changed its name and approach to promote the entire biotech industry.
 / PBN PHOTO/MICHAEL SALERNO

Ocean State starting to see growth in biotech industry

Focus
RI BIO, a Providence-based biotechnology trade association, is on a mission to put Rhode Island on the biotech industry’s map. Despite the state having...
IN COLLABORATION: Amgen Rhode Island employees discuss manufacturing data on a display screen at the West Greenwich facility. From left are manager Jennifer Gangi, senior associate Kelly Perry, associate David Folco, manager Jon Berthiaume and manager Gary Theroux.
 / PBN PHOTO/RUPERT WHITELEY

Amgen Rhode Island workers reap rewards of ‘Caring’

PBN Award Winners
Best Places to Work 2019 | ENTERPRISE (500-plus employees): 1. Amgen Rhode Island WITH CAREFUL PLANNING, Amgen Rhode Island is utilizing innovation to get its...

Amgen biomanufacturing plant coming soon, bringing jobs, efficiency

Technology
WEST GREENWICH – With the foundation ready, next month Amgen Inc. will begin modular construction of its $165 million next-generation biomanufacturing plant on its...
1234Page 1 of 4

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

By submitting your information you are agreeing to our Privacy Policy and Terms of Use

- Featured Event -

Latest News

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.

Subscribe

SIGN UP FOR

PBN's Daily Newsletter

Get PBN's top stories every morning in your email inbox.

FOLLOW US

@ProvBusNews

Follow PBN for the latest news, insider access and more.

MOST POPULAR

OUR MISSION

To be the trusted business news and information source for the Rhode Island and Southeastern MA business community providing timely, insightful, in-depth and breaking news coverage that advances individual and company growth and success in local, state and global markets.

ABOUT PBN

© Providence Business News. All Rights Reserved.

Privacy   |   Terms of Use

Register to read all articles free - This week only!

CLOSE

One week only, get full access to all articles on PBN.com when you create a complimentary account.

One week only, get full access to all articles on PBN.com when you create a complimentary account.

 

Register today >>

Sign-up to get the

PBN Daily Edition

A collection of all the published news of the last 24 hours, as well as selected features from PBN’s weekly print edition.

By submitting the form you agree to PBN's Privacy Policy and Terms of Use.

Unfortunately, you have run out of free stories. Fortunately, if you register now you can keep reading with limited access or for unlimited access subscribe for $4 for 4 weeks.

We’re glad you are enjoying PBN.